13 NASDAQ Stocks with Highest Dividends

8. Gilead Sciences, Inc. (NASDAQ:GILD)

Dividend Yield as of April 12: 2.36%

On April 10, Morgan Stanley raised the firm’s price recommendation on Gilead Sciences, Inc. (NASDAQ:GILD) to $175 from $171. It kept an Overweight rating on the shares. The firm updated its models across biopharma coverage, reflecting IQVIA trends and intra-quarter updates ahead of Q1 earnings.

For the first quarter of 2026, Gilead Sciences expects about $107 million in acquired IPR&D expenses. This represents a charge of around $0.07 to both GAAP and non-GAAP diluted earnings per share. These expenses can include, in any given quarter, known commitments tied to previously announced collaborations and partnerships. They may also include upfront and other costs linked to new business development activities during the period.

In Q1 2026, the total includes an upfront payment of about $80 million related to the Genhouse collaboration announced on February 13, 2026. This amount was not included in the full-year 2026 IPR&D guidance of $300 million provided on February 10, 2026.

Gilead Sciences, Inc. (NASDAQ:GILD) is a biopharmaceutical company focused on developing treatments for serious diseases. Its work spans areas such as HIV, viral hepatitis, COVID-19, cancer, and inflammation. The company focuses on discovering, developing, and delivering medicines to address unmet needs across virology, oncology, and other therapeutic areas.